![Michael Kyriakides](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kyriakides
Direktor/Vorstandsmitglied bei
Purespring Therapeutics Ltd.
Profil
Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.
Aktive Positionen von Michael Kyriakides
| Unternehmen | Position | Beginn |
|---|---|---|
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Direktor/Vorstandsmitglied | 01.04.2022 |
Ehemalige bekannte Positionen von Michael Kyriakides
| Unternehmen | Position | Ende |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | - |
Ausbildung von Michael Kyriakides
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
